Last updated: 10 July 2024 at 9:57am EST

Alison Ives Net Worth




The estimated Net Worth of Alison Ives is at least $506 Thousand dollars as of 8 July 2024. Ms Ives owns over 920 units of Perrigo plc stock worth over $505,999 and over the last 2 years she sold PRGO stock worth over $0.

Ms Ives PRGO stock SEC Form 4 insiders trading

Ms has made over 10 trades of the Perrigo plc stock since 2022, according to the Form 4 filled with the SEC. Most recently she exercised 920 units of PRGO stock worth $23,662 on 8 July 2024.

The largest trade she's ever made was exercising 3,776 units of Perrigo plc stock on 6 March 2024 worth over $108,862. On average, Ms trades about 1,317 units every 49 days since 2022. As of 8 July 2024 she still owns at least 18,930 units of Perrigo plc stock.

You can see the complete history of Ms Ives stock trades at the bottom of the page.





Ms. Alison Ives biography

Alison Ives is the Exec. VP & Chief Scientific Officer at Perrigo plc.



What's Ms Ives's mailing address?

Alison's mailing address filed with the SEC is C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN, MI, 49010.

Insiders trading at Perrigo plc

Over the last 11 years, insiders at Perrigo plc have traded over $21,020,805 worth of Perrigo plc stock and bought 592,512 units worth $38,708,035 . The most active insiders traders include Jeffrey C Smith, Gary M Cohen, and Joseph C Papa. On average, Perrigo plc executives and independent directors trade stock every 11 days with the average trade being worth of $156,424. The most recent stock trade was executed by Ronald Craig Janish on 26 August 2024, trading 13,000 units of PRGO stock currently worth $382,200.



What does Perrigo plc do?

perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).



What does Perrigo plc's logo look like?

Perrigo Company plc logo

Complete history of Ms Ives stock trades at Perrigo plc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
8 Jul 2024 Alison Ives
EVP and Chief Scientific Officer
Option 920 $25.72 $23,662
8 Jul 2024
18,930
6 Mar 2024 Alison Ives
EVP and Chief Scientific Officer
Option 3,776 $28.83 $108,862
6 Mar 2024
18,536
5 Mar 2024 Alison Ives
EVP and Chief Scientific Officer
Buy 2,490 $27.26 $67,877
5 Mar 2024
16,122
29 Feb 2024 Alison Ives
EVP and Chief Scientific Officer
Buy 1,545 $26.44 $40,850
29 Feb 2024
12,446
16 Nov 2023 Alison Ives
EVP and Chief Scientific Officer
Buy 2,040 $29.34 $59,854
16 Nov 2023
10,380
6 Oct 2023 Alison Ives
EVP and Chief Scientific Officer
Option 738 $30.46 $22,479
6 Oct 2023
9,078
7 Jul 2023 Alison Ives
EVP and Chief Scientific Officer
Option 920 $32.63 $30,020
7 Jul 2023
8,611
7 Mar 2023 Alison Ives
EVP and Chief Scientific Officer
Option 1,746 $37.71 $65,842
7 Mar 2023
8,201
3 Mar 2023 Alison Ives
EVP and Chief Scientific Officer
Option 2,208 $38.75 $85,560
3 Mar 2023
7,090
7 Oct 2022 Alison Ives
EVP and Chief Scientific Officer
Option 739 $38.09 $28,149
7 Oct 2022
4,973


Perrigo plc executives and stock owners

Perrigo plc executives and other stock owners filed with the SEC include: